Current collaborations

 

Adjuvantix are currently working with:

 

Pro-Cure Therapeutics - development of the ADX40-prostate cancer vaccine

The Health Protection agency - development of ADX40-TB

The Institut Pasteur, Brussels - development of ADX40-TB

Partnering